Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 5
2006 2
2008 2
2010 1
2011 1
2012 3
2015 1
2016 3
2017 5
2018 4
2019 6
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C, Trafalis DT. Alifieris C, et al. Among authors: trafalis dt. Pharmacol Ther. 2015 Aug;152:63-82. doi: 10.1016/j.pharmthera.2015.05.005. Epub 2015 May 2. Pharmacol Ther. 2015. PMID: 25944528 Review.
Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy.
Constantinidou A, Alifieris C, Trafalis DT. Constantinidou A, et al. Among authors: trafalis dt. Pharmacol Ther. 2019 Feb;194:84-106. doi: 10.1016/j.pharmthera.2018.09.008. Epub 2018 Sep 28. Pharmacol Ther. 2019. PMID: 30268773 Review.
The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents.
Mitsiogianni M, Koutsidis G, Mavroudis N, Trafalis DT, Botaitis S, Franco R, Zoumpourlis V, Amery T, Galanis A, Pappa A, Panayiotidis MI. Mitsiogianni M, et al. Among authors: trafalis dt. Antioxidants (Basel). 2019 Apr 18;8(4):106. doi: 10.3390/antiox8040106. Antioxidants (Basel). 2019. PMID: 31003534 Free PMC article. Review.
Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma.
Trafalis DT, Alifieris CE, Kalantzis A, Verigos KE, Vergadis C, Sauvage S. Trafalis DT, et al. J Immunother. 2018 Jul/Aug;41(6):300-305. doi: 10.1097/CJI.0000000000000221. J Immunother. 2018. PMID: 29642086
Parathyroid hormone related protein (PTHrP)-mediated hypercalcemia in malignancy associated with anti-PD-1 immune checkpoint inhibitor treatment and related inflammatory reactions.
Deligiorgi MV, Panayiotidis MI, Trafalis DT. Deligiorgi MV, et al. Among authors: trafalis dt. Int Immunopharmacol. 2019 Dec;77:105942. doi: 10.1016/j.intimp.2019.105942. Epub 2019 Nov 4. Int Immunopharmacol. 2019. PMID: 31699669
Novel Docosahexaenoic Acid Ester of Phloridzin Inhibits Proliferation and Triggers Apoptosis in an In Vitro Model of Skin Cancer.
Mantso T, Trafalis DT, Botaitis S, Franco R, Pappa A, Rupasinghe HPV, Panayiotidis MI. Mantso T, et al. Among authors: trafalis dt. Antioxidants (Basel). 2018 Dec 11;7(12):188. doi: 10.3390/antiox7120188. Antioxidants (Basel). 2018. PMID: 30544916 Free PMC article.
Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
Geromichalos GD, Alifieris CE, Geromichalou EG, Trafalis DT. Geromichalos GD, et al. Among authors: trafalis dt. J BUON. 2016 Nov-Dec;21(6):1337-1358. J BUON. 2016. PMID: 28039691 Free article. Review.
Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study.
Tampaki EC, Tampakis A, Alifieris CE, Krikelis D, Pazaiti A, Kontos M, Trafalis DT. Tampaki EC, et al. Among authors: trafalis dt. Clin Drug Investig. 2018 Jul;38(7):639-648. doi: 10.1007/s40261-018-0655-z. Clin Drug Investig. 2018. PMID: 29744672 Clinical Trial.
Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD, Alifieris CE, Geromichalou EG, Trafalis DT. Geromichalos GD, et al. Among authors: trafalis dt. J BUON. 2016 Jul-Aug;21(4):764-779. J BUON. 2016. PMID: 27685895 Free article. Review.
The arbitrary magic of p<0.05: Beyond statistics.
E Alifieris C, Souferi Chronopoulou E, T Trafalis D, Arvelakis A. E Alifieris C, et al. Among authors: t trafalis d. J BUON. 2020 Mar-Apr;25(2):588-593. J BUON. 2020. PMID: 32521838 Free article.
42 results
Jump to page
Feedback